Tag: lilly
-
Halozyme’s pancreatic cancer drug succeeds in mid-stage trial
(Reuters) – Halozyme Therapeutics Inc said its flagship drug delivery technology in tandem with therapies from Celgene Corp and Eli Lilly and Co succeeded in a mid-stage study involving patients with an advanced form of pancreatic cancer. Shares of Halozyme were up 47.3 percent at $15.77 in trading before the opening bell on Thursday. Halozyme’s…
-
Alzheimer’s setback prompts rethink of Lilly, Biogen stock outlooks
By Lewis Krauskopf NEW YORK (Reuters) – Eli Lilly & Co’s massive setback for its experimental Alzheimer’s disease treatment on Wednesday sent investors scrambling to re-evaluate shares of the U.S. drugmaker and those of companies making competing therapies, including biotech stalwart Biogen Inc. Lilly shares tumbled 10.5 percent, and fell to their lowest point in…